Letter: screening for adrenal suppression in paediatric inflammatory bowel disease – authors’ reply

Abstract

Linked ContentThis article is linked to Philpott et al and Wood and Henderson papers. To view these articles visit https://doi.org/10.1111/apt.14573 and https://doi.org/10.1111/apt.14861.

Letter: screening for adrenal suppression in paediatric inflammatory bowel disease

“…This is in stark contrast to other specialties who have adopted a more consistent approach, notably screening of children receiving high-dose inhaled corticosteroids for asthma, following high-profile fatalities and a recognition of the morbidity of chronic adrenal insufficiency symptoms. 6 Following the work of Philpott et al in eosinophilic oesophagitis, a comprehensive review of literature reporting rates of AS in IBD, as well as prospective studies (ideally using ACTH stimulation testing) in both these populations, is also needed to better inform what is currently a highly variable practice. We also applaud their efforts in obtaining practical data that highlight the importance of testing for adrenal insufficiency, and the contrasting lack of consistent evaluation of this at-risk group.…”